Losartan Potassium 50mg coated tablets
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 4 defect notification
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Losartan Potassium 50mg coated tablets | PL: 45841/0015 | losartan potassium | 5055144202617 |
| Losartan Potassium 100mg coated tablets | PL: 45841/0013 | losartan potassium | 5055144202624 |
| Losartan potassium/Hydrochlorothiazide 50mg/12.5mg coated tablets | PL: 20395/0109 | losartan potassium and hydrochlorothiazide | 5055144202617 |
| Losartan potassium/Hydrochlorothiazide 100mg/25mg coated tablets | PL: 20395/0108 | losartan potassium and hydrochlorothiazide | 5055144202624 |
| Risperidone 0.5mg Tablets (Almus livery) | PL: 20395/0290 | Risperidone |
Background: Losartan potassium & Losartan potassium/hydrochlorothiazide tablets Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to Losartan potassium/Hydrochlorothiazide 50mg/12.5mg and 100mg/25mg coated tablets in error. The GTIN numbers were originally assigned to Losartan Potassium 50mg coated tablets and Losartan Potassium 100mg coated tablets, respectively. The reused barcodes were reported to the Defective Medicines Report Centre (DMRC) by a pharmacy that uses robotic dispensing. The following products have the duplicated barcodes: Losartan potassium/Hydrochlorothiazide 50mg/12.5mg coated tablets have the same GTIN number as Losartan Potassium 50mg coated tablets.